Additionally, the modulatory effects of insulin and caloric intake on MCP-1 levels were mainly examined in either healthy obese or noncritically ill patients with type 2 diabetes rather than in the ICU setting. This evidence concerns the gene CCL2 and type 2 diabetes mellitus.